Bo Liang

No ORCID on file · 9 papers in corpus · active 2012-2025

Study types

  • article 6
  • other 3

Condition tags

  • endometriosis 8
  • mesh:D004715 4
  • bladder_endometriosis 1
other 2025
Correction: Receptor tyrosine kinase inhibitor sunitinib as novel immunotherapy to inhibit myeloid-derived suppressor cells for treatment of endometriosis
Frontiers in immunology ·doi:10.3389/fimmu.2025.1741271

[This corrects the article DOI: 10.3389/fimmu.2021.641206.].

article 2025
In situ pro-regenerative and repair capabilities of human umbilical mesenchymal stem cells and collagen hydrogel complex in mice with thin endometrium
·doi:10.1016/j.actbio.2025.10.026
other 2024
Unique anti-angiogenic effects, pharmacological targets and therapeutic mechanisms of Chinese herbal medicines for endometriosis
Genes & diseases ·doi:10.1016/j.gendis.2023.101166
article 2022
Re-evaluation of mouse models of endometriosis for pathological and immunological research
Frontiers in immunology ·doi:10.3389/fimmu.2022.986202

Endometriosis is an estrogen-dependent gynecological disease with chronic pelvic inflammation. In order to study the pathophysiology of endometriosis and examine the therapeutic effects of new pharmaceuticals for endometriosis treatment, di…

article 2021
An In-Silico, In-Vitro and In-Vivo Combined Approach to Identify NMNATs as Potential Protein Targets of ProEGCG for Treatment of Endometriosis
Frontiers in pharmacology ·doi:10.3389/fphar.2021.714790

Endometriosis is defined as endometrial tissues found outside the uterine cavity. ProEGCG is a prodrug of Epigallocatechin gallate (EGCG), a potent polyphenol found in green tea. It inhibits the development of endometriotic lesions of mouse…

article 2021
Receptor Tyrosine Kinase Inhibitor Sunitinib as Novel Immunotherapy to Inhibit Myeloid-Derived Suppressor Cells for Treatment of Endometriosis
Frontiers in immunology ·doi:10.3389/fimmu.2021.641206

Endometriosis is a common, benign, and hormone-dependent gynaecological disorder that displays altered immunoinflammatory profiles. Myeloid-derived suppressor cells (MDSCs) suppressed immunosurveillance in endometriosis in human and mouse m…

other 2018
Efficacy, safety and recurrence of new progestins and selective progesterone receptor modulator for the treatment of endometriosis: a comparison study in mice
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-018-0347-9

BACKGROUND: Current medical treatments for endometriosis are very limited. Progestin and selective progesterone receptor modulators (SPRM) are developed but their efficacy, safety, mechanism and recurrence in endometriosis are not fully stu…

article 2018
MDSCs drive the process of endometriosis by enhancing angiogenesis and are a new potential therapeutic target
European journal of immunology ·doi:10.1002/eji.201747417

Endometriosis affects women of reproductive age via unclear immunological mechanism(s). Myeloid-derived suppressor cells (MDSCs) are a heterogeneous group of myeloid cells with potent immunosuppressive and angiogenic properties. Here, we fo…

article 2012
Diagnosis and treatment of bladder endometriosis
·doi:10.3760/cma.j.issn.1000-6702.2012.12.011

Objective To investigate the clinical feature,diagnosis,treatment and prognosis of endometriosis of the bladder.Methods A retrospective study was conducted to review the clinical data of 10 patients with bladder endometriosis.Patient's age …